JP2004526758A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526758A5
JP2004526758A5 JP2002580892A JP2002580892A JP2004526758A5 JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5 JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5
Authority
JP
Japan
Prior art keywords
tsp
composition
angiogenesis inhibitor
cosmetic
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011403 external-priority patent/WO2002083088A1/en
Publication of JP2004526758A publication Critical patent/JP2004526758A/ja
Publication of JP2004526758A5 publication Critical patent/JP2004526758A5/ja
Pending legal-status Critical Current

Links

JP2002580892A 2001-04-13 2002-04-11 紫外線bにより誘導される皮膚損傷の予防法 Pending JP2004526758A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (2)

Publication Number Publication Date
JP2004526758A JP2004526758A (ja) 2004-09-02
JP2004526758A5 true JP2004526758A5 (cg-RX-API-DMAC7.html) 2005-08-18

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580892A Pending JP2004526758A (ja) 2001-04-13 2002-04-11 紫外線bにより誘導される皮膚損傷の予防法

Country Status (8)

Country Link
US (1) US6712617B2 (cg-RX-API-DMAC7.html)
EP (1) EP1377253A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004526758A (cg-RX-API-DMAC7.html)
KR (2) KR20040021598A (cg-RX-API-DMAC7.html)
CN (1) CN100340287C (cg-RX-API-DMAC7.html)
CA (1) CA2446093A1 (cg-RX-API-DMAC7.html)
TW (1) TWI233361B (cg-RX-API-DMAC7.html)
WO (1) WO2002083088A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
JP5122060B2 (ja) * 2002-06-25 2013-01-16 株式会社 資生堂 抗老化剤
US7256178B2 (en) * 2002-07-31 2007-08-14 Eisai Co., Ltd. Physiologically active substances
EP1541570A4 (en) * 2002-07-31 2008-05-21 Mercian Corp NEW PHYSIOLOGICALLY EFFECTIVE SUBSTANCE
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
RU2330069C2 (ru) * 2002-11-29 2008-07-27 Мершан Корпорейшн Способ получения макролидного соединения и штаммы streptomyces sp., mortierella sp. и micromonosporaceae
US20050281761A1 (en) * 2004-04-01 2005-12-22 Michael Detmar Methods of preventing UVB-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US8795315B2 (en) * 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
KR101160765B1 (ko) 2004-10-12 2012-06-28 어웨어, 인크. 트랜시버에서의 메모리 할당 방법
CA2607142C (en) * 2005-05-05 2014-03-25 Genencor International, Inc. Personal care compositions and methods for their use
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NEW HEMMER OF THE EXPRESSION OF VASCULAR ENDOTHEL GROWTH FACTOR
DE602007008365D1 (de) 2006-01-18 2010-09-23 Gen Hospital Corp Verfahren zur steigerung der lymphatischen funktion
EP2005674B1 (en) 2006-04-12 2016-09-28 TQ Delta, LLC Packet retransmission and memory sharing
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
CA2659562A1 (en) * 2006-08-14 2008-02-21 Eisai R&D Management Co., Ltd. Stable lyophilized preparation
NZ575828A (en) * 2007-01-29 2011-04-29 Eisai R&D Man Co Ltd Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
TW200918099A (en) 2007-09-14 2009-05-01 Nitto Denko Corp Drug carriers
US9132202B2 (en) 2009-07-17 2015-09-15 Aaron T. Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
JP2023512423A (ja) 2019-12-24 2023-03-27 ジュベナ・セラピューティクス・インコーポレイテッド 再生性ポリペプチドおよびその使用
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
CN117999278A (zh) 2021-06-21 2024-05-07 裘美娜治疗公司 再生性多肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
KR20010013047A (ko) * 1997-05-27 2001-02-26 존흐휴알. 기름체의 용도
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
AU1597199A (en) * 1997-11-25 1999-06-15 Cornell Research Foundation Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
KR20010105403A (ko) 1999-03-31 2001-11-28 마빈 씨. 구트리 트롬보스폰딘-2 및 이의 용도
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Similar Documents

Publication Publication Date Title
JP2004526758A5 (cg-RX-API-DMAC7.html)
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
Adebajo et al. A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis
ES2310010T3 (es) Composiciones viscosas que contienen dioxido de carbono.
JP2002532432A5 (cg-RX-API-DMAC7.html)
CA2600384C (en) Compositions and methods for treating acne
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
JP2004505007A5 (cg-RX-API-DMAC7.html)
DE799037T1 (de) Verfahren und mittel zur behandlung der allergischen rhinitis und anderer erkrankungen mittels descarboethoxyloratadin
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
Stagnone Superficial peeling
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
US5753213A (en) Pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts for reducing seborrhea
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
US20160235847A1 (en) Nail fungus treatment and composition
JP2004532268A (ja) 異常な角質性物質を除去するための製剤
JP2013163681A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
AU709422B2 (en) Method for topical treatment of scar tissue and related tissue reaction to trauma
JPH05194140A (ja) 硫黄原子を持つアミノ酸を含有する爪処置用組成物
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
DE69910600D1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
MX2023009424A (es) Composicion antitranspirante.